Anti-platelet Therapy Completed Phase 2 Trials for Ticagrelor (DB08816)

Also known as: Antiplatelet Therapy

IndicationStatusPhase
DBCOND0058194 (Anti-platelet Therapy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03039205Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or TicagrelorTreatment